| NCT ID | NCT04837755 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Universität des Saarlandes |
| Condition | Covid19 |
| Study Type | OBSERVATIONAL |
| Enrollment | 300 participants |
| Start Date | 2020-03-01 |
| Primary Completion | 2025-12-31 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 300 participants in total. It began in 2020-03-01 with a primary completion date of 2025-12-31.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The CORSAAR study is an observational, prospective study to investigate the natural biology of COVID-19
Eligibility Criteria
Inclusion Criteria: all form of COVID-19 including long-COVID-19 Exclusion Criteria: \-
Contact & Investigator
Frequently Asked Questions
Who can join the NCT04837755 clinical trial?
This trial is open to participants of all sexes, aged 0 Years or older, up to 110 Years, studying Covid19. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04837755 currently recruiting?
Yes, NCT04837755 is actively recruiting participants. Contact the research team at robert.bals@uks.eu for enrollment information.
Where is the NCT04837755 trial being conducted?
This trial is being conducted at Homburg, Germany.
Who is sponsoring the NCT04837755 clinical trial?
NCT04837755 is sponsored by Universität des Saarlandes. The trial plans to enroll 300 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.